 In 2007 Meyers announced her retirement from the NORD presidency; the president is now Peter Saltonstall.Since its founding in 1983, NORD continued to grow with the help of federal grants and donations.NORD's operations include funding research on treatment and cures for rare diseases; lobbying for legislation to benefit the rare diseases community (in addition to the Orphan Drug Act, NORD has helped bring about legislation on publicizing clinical trials on the Internet, to give the public and medical professionals warning about projected drug shortages, and on the development of medical devices); spreading information about rare diseases; and helping individuals with rare diseases afford medication and treatment.